======= BUD31 ======= == Gene Information == * **Official Symbol**: BUD31 * **Official Name**: BUD31 homolog * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8896|8896]] * **UniProt**: [[https://www.uniprot.org/uniprot/P41223|P41223]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BUD31&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BUD31|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603477|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |G10| |positive regulation of androgen receptor activity| |nuclear hormone receptor binding| |U2-type catalytic step 2 spliceosome| |nuclear receptor transcription coactivator activity| |spliceosomal complex| |nuclear chromatin| |positive regulation of DNA-binding transcription factor activity| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |RNA splicing, via transesterification reactions| |RNA splicing| |regulation of DNA-binding transcription factor activity| |mRNA processing| |mRNA metabolic process| |RNA processing| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |RNA metabolic process| |positive regulation of RNA metabolic process| |positive regulation of molecular function| |positive regulation of cell communication| |positive regulation of signaling| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp33|Rotenone 2μM R00 exp33]]|-1.78| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.72| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|1.77| |[[:results:exp481|Ethambutol 25μM R08 exp481]]|1.83| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|1.85| |[[:results:exp210|LB-100 2μM R05 exp210]]|2.31| |[[:results:exp277|Curcumin 6.5μM R06 exp277]]|2.39| ^Gene^Correlation^ |[[:human genes:p:prim1|PRIM1]]|0.529| |[[:human genes:p:psmb4|PSMB4]]|0.409| Global Fraction of Cell Lines Where Essential: 737/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|27/28| |bone|26/26| |breast|32/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|21/21| |liver|20/20| |lung|75/75| |lymphocyte|16/16| |ovary|26/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 193 * **Expression level (log2 read counts)**: 5.42 {{:chemogenomics:nalm6 dist.png?nolink |}}